[The diagnosis, biopsy and treatment follow-up by ultrasound in patients with prostatic carcinoma].
Prostate carcinoma accounts for 1-5 per cent of all neoplasms affecting men, and represents 29.2 per cent of the tumors involving the urogenital system. It is a disease encountered in advanced age mainly--between 60 and 70 years, and recently even earlier. It is pointed out that transrectal ultrasound examination is usually used for diagnosing prostate carcinoma, determination of its stage, and follow-up study of the treatment effect. The clinical relevance of transrectal echography augments whenever performed in conjunction with biopsy of the prostate under ultrasound control, especially in the event of impalpable neoformation, or in uncertain negative, digitally oriented biopsies. The screening method proposed is capable to provide for a sufficiently accurate orientation towards the site for performing control biopsy of the prostate, but it could hardly serve as a reliable, independent criterion for estimating the effect of the nonoperative treatment in course.